Andrew Joseph Muir, MD

Professor of Medicine
Chief, Division of Gastroenterology in the Department of Medicine
Core Faculty in Innovation & Entrepreneurship
Member in the Duke Clinical Research Institute
Campus mail 03137B Hosp South, Durham, NC 27710
Phone (919) 684-2052
Email address andrew.muir@duke.edu
  • Hepatitis C 
  • Primary sclerosing cholangitis
  • Cirrhosis
  • Liver Transplantation
  • Clinical Trials
  • Healthcare disparities in liver disease 
  • Outcomes Research

Education and Training

  • Fellow in Gastroenterology, Medicine, Duke University, 1998 - 2000
  • Chief Medical Resident, Medicine, Duke University, 1997 - 1998
  • Fellow in Gastroenterology, Medicine, Duke University, 1996 - 1997
  • Medical Resident, Medicine, Duke University, 1993 - 1996
  • M.H.S., Duke University, 2001
  • M.D., Duke University, 1993

Grants

Publications

Trauner, Michael H., Yevgeniy Gindin, Jing Zhu Zhou, Ryan Huss, Chuhan Chung, Mani Subramanian, Robert P. Myers, et al. “RNA-SEQ FROM PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS IDENTIFIES A FIBROSIS-INDEPENDENT GENE EXPRESSION SIGNATURE THAT PREDICTS CLINICAL EVENTS.” In Hepatology, 70:758A-759A. WILEY, 2019.

Scholars@Duke

Sulkowski, Mark S., Annie Luetkemeyer, Stuart C. Gordon, Andrew J. Muir, Claudia Martorell, George M. Savage, Todd Young, Sophia Li, Richard McLain, and Gregory Huhn. “EFFICACY AND ADHERENCE TO ORAL HEPATITIS C (HCV) TREATMENT THROUGH A DIGITAL MEDICINE PROGRAM (DMP) AMONG A POPULATION AT HIGH RISK FOR NONADHERENCE.” In Hepatology, 70:936A-936A. WILEY, 2019.

Scholars@Duke

Patel, Yuval, Alice Parish, Donna Niedzwiecki, Andrew J. Muir, and Deborah Fisher. “A LARGE PROPORTION OF NAFLD PATIENTS WITH ADVANCED FIBROSIS REMAIN CLINICALLY UNIDENTIFIED: AN ANALYSIS OF PCORNET DATA.” In Hepatology, 70:375A-376A. WILEY, 2019.

Scholars@Duke

Jacobson, Ira M., Andrew J. Muir, Eric J. Lawitz, Edward J. Gane, Brian Conway, Peter J. Ruane, Ziad Younes, et al. “COURSE OF CIRRHOSIS REGRESSION: LESSONS FROM PATIENTS WITH HCV CIRRHOSIS FOLLOWING SUCCESSFUL SOFOSBUVIR-BASED TREATMENT.” In Hepatology, 70:339A-339A. WILEY, 2019.

Scholars@Duke

Younossi, Zobair M., Maria Stepanova, Eric J. Lawitz, K Rajender Reddy, Vincent Wai-Sun Wong, Alessandra Mangia, Andrew J. Muir, et al. “Patients With Nonalcoholic Steatohepatitis Experience Severe Impairment of Health-Related Quality of Life.” Am J Gastroenterol 114, no. 10 (October 2019): 1636–41. https://doi.org/10.14309/ajg.0000000000000375.

PMID
31464743
Full Text

Chiang, Ryan S., Ahmad Farooq, Alice Parish, Donna Niedzwiecki, Matthew R. Kappus, Yuval Patel, Rodger A. Liddle, and Andrew J. Muir. “1089 Hypophosphatemia in Patients With Alcoholic Hepatitis.” In American Journal of Gastroenterology, 114:S615–16. Ovid Technologies (Wolters Kluwer Health), 2019. https://doi.org/10.14309/01.ajg.0000593888.05451.17.

Full Text

Trauner, Michael, Aliya Gulamhusein, Bilal Hameed, Stephen Caldwell, Mitchell L. Shiffman, Charles Landis, Bertus Eksteen, et al. “The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS-9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis.” Hepatology 70, no. 3 (September 2019): 788–801. https://doi.org/10.1002/hep.30509.

PMID
30661255
Full Text

Zhang, Xiaojie, Sarah Burroughs, Ahmad Farooq, Mustafa R. Bashir, Andrew J. Muir, and Yuval A. Patel. “N-Acetylcysteine in the Management of Acute Liver Failure From Sickle Cell Hepatic Crisis.” Acg Case Rep J 6, no. 8 (August 2019): e00161. https://doi.org/10.14309/crj.0000000000000161.

PMID
31737700
Full Text

Di Bisceglie, Adrian M., Wendy C. King, Mauricio Lisker-Melman, Mandana Khalili, Steven H. Belle, Jordan J. Feld, Marc G. Ghany, et al. “Age, race and viral genotype are associated with the prevalence of hepatitis B e antigen in children and adults with chronic hepatitis B.” J Viral Hepat 26, no. 7 (July 2019): 856–65. https://doi.org/10.1111/jvh.13104.

PMID
30974509
Full Text

Hirschfield, Gideon M., Olivier Chazouillères, Joost P. Drenth, Douglas Thorburn, Stephen A. Harrison, Charles S. Landis, Marlyn J. Mayo, et al. “Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trial.” J Hepatol 70, no. 3 (March 2019): 483–93. https://doi.org/10.1016/j.jhep.2018.10.035.

PMID
30414864
Full Text

Pages